|
RAB4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.070000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.354800E-01 |
| Normal-vs-Stage2 |
4.193000E-01 |
| Normal-vs-Stage3 |
1.542200E-02 |
| Normal-vs-Stage4 |
5.429900E-04 |
| Stage1-vs-Stage2 |
5.271600E-01 |
| Stage1-vs-Stage3 |
2.963700E-03 |
| Stage1-vs-Stage4 |
1.006050E-04 |
| Stage2-vs-Stage3 |
1.758430E-02 |
| Stage2-vs-Stage4 |
1.683690E-03 |
| Stage3-vs-Stage4 |
3.021200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.722620E-01 |
| Normal-vs-AfricanAmerican |
6.840800E-01 |
| Normal-vs-Asian |
9.224000E-01 |
| Caucasian-vs-AfricanAmerican |
7.385800E-01 |
| Caucasian-vs-Asian |
8.511800E-01 |
| AfricanAmerican-vs-Asian |
9.596800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.924180E-01 |
| Normal-vs-Female |
4.287800E-01 |
| Male-vs-Female |
7.017400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.736350E-01 |
| Normal-vs-Age(41-60Yrs) |
3.682600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.247600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.308200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.370000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.535600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.753800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.382800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.445000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.682800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.221700E-03 |
| Normal-vs-Grade 2 |
3.988200E-01 |
| Normal-vs-Grade 3 |
1.362180E-01 |
| Normal-vs-Grade 4 |
1.66539999999493E-05 |
| Grade 1-vs-Grade 2 |
1.308960E-01 |
| Grade 1-vs-Grade 3 |
2.700200E-02 |
| Grade 1-vs-Grade 4 |
2.633700E-04 |
| Grade 2-vs-Grade 3 |
1.992320E-02 |
| Grade 2-vs-Grade 4 |
9.27779999493339E-08 |
| Grade 3-vs-Grade 4 |
7.389100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.538340E-02 |
| Normal-vs-ccB subtype |
6.298900E-03 |
| ccA subtype-vs-ccB subtype |
7.91539999989155E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.764040E-01 |
| Normal-vs-N1 |
1.171990E-01 |
| N0-vs-N1 |
1.713010E-01 |
|
|
